Advanced Solid Tumors Harboring Kras G12c Mutation clinical trials

Explore recruiting advanced solid tumors harboring kras g12c mutation clinical trials.

Recruiting advanced solid tumors harboring kras g12c mutation studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Advanced Solid Tumors Harboring Kras G12c Mutation trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A study to learn BAY 3498264 when given alone or together with sotorasib in participants who have advanced solid cancers with specific genetic changes called KRASG12C mutation

Italy, Spain, Denmark

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

A Phase 1/2, Multi-Center, Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Evidence of Antitumor Activity of JAB-21822 Monotherapy and Combination Therapy in Adult Patients with Advanced Solid Tumors Harboring KRAS G12C Mutation

Spain

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

Advanced Solid Tumors Harboring Kras G12c Mutation trials by city

Advanced Solid Tumors Harboring Kras G12c Mutation in Toronto Advanced Solid Tumors Harboring Kras G12c Mutation in Vancouver Advanced Solid Tumors Harboring Kras G12c Mutation in Montreal Advanced Solid Tumors Harboring Kras G12c Mutation in Calgary Advanced Solid Tumors Harboring Kras G12c Mutation in Edmonton Advanced Solid Tumors Harboring Kras G12c Mutation in Ottawa Advanced Solid Tumors Harboring Kras G12c Mutation in Winnipeg Advanced Solid Tumors Harboring Kras G12c Mutation in Quebec City Advanced Solid Tumors Harboring Kras G12c Mutation in Hamilton Advanced Solid Tumors Harboring Kras G12c Mutation in Kitchener Advanced Solid Tumors Harboring Kras G12c Mutation in London Advanced Solid Tumors Harboring Kras G12c Mutation in Halifax Advanced Solid Tumors Harboring Kras G12c Mutation in New York Advanced Solid Tumors Harboring Kras G12c Mutation in Los Angeles Advanced Solid Tumors Harboring Kras G12c Mutation in Chicago Advanced Solid Tumors Harboring Kras G12c Mutation in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease